The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery.
OBJECTIVE
To investigate the role of low serum magnesium as a trigger for atrial fibrillation in patients with a substrate for the arrhythmia (assessed by signal averaged P wave duration).


METHODS
A case-control study.


METHODS
A regional referral cardiac centre.


METHODS
105 consecutive patients undergoing elective coronary artery bypass surgery had signal averaged P wave recordings before operation. Serum electrolytes were analysed preoperatively and on days 1, 2, and 5 after surgery.


METHODS
Any episode of electrocardiographically recorded atrial fibrillation was taken as a study end point.


RESULTS
Of 102 patients discharged, 27 (26%) had documented episodes of atrial fibrillation at a mean of 2.7 days after surgery. A combination of P wave duration > 155 ms and serum magnesium on the first postoperative day of < 0.7 mmol/l had a sensitivity of 75% and specificity of 80% for predicting atrial fibrillation. Duration of hospital stay (7.9 v 6.8 days) was longer in the atrial fibrillation group (P < 0.01). Stepwise regression showed age, serum magnesium < 0.7 mmol/l on the first postoperative day (both P < 0.001), angiotensin converting enzyme inhibitor withdrawal (P < 0.02), and signal averaged P wave duration (P = 0.04) to be independent predictors.


CONCLUSIONS
The combination of signal averaged P wave duration and low serum magnesium on the first postoperative day identified the majority of patients with atrial fibrillation after coronary artery bypass surgery. Early identification and pharmacological treatment for selected patients may reduce the incidence of postoperative atrial fibrillation.
Zaman
A G
AG
Department of Cardiology, Royal Hospitals NHS Trust, London, United Kingdom.
Alamgir
F
F
Richens
T
T
Williams
R
R
Rothman
M T
MT
Mills
P G
PG
D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood / Q000175:diagnosis*; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000097:blood / Q000150:complications / Q000601:surgery; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008274:Magnesium / Q000097:blood*; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis*; D011379:Prognosis; D012044:Regression Analysis; D012815:Signal Processing, Computer-Assisted; D013686:Telemetry
D015415:Biomarkers; D008274:Magnesium